sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), By Regions (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast up to 2025

Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone...

Home / Categories / Healthcare
Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), By Regions (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast up to 2025
Osteoporosis Drugs Market - By...
Report Code
RO3/122/1059

Publish Date
08/May/2024

Pages
70
PRICE
$ 2750/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3500/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 4500/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Tables

TABLE 1 GLOBAL OSTEOPOROSIS DRUGS MARKET REVENUE, BY REGIONS, 2018-2025 ($MILLION) 39
TABLE 2 OTHER VENDORS IN THE OSTEOPOROSIS DRUGS MARKET 46
TABLE 3 BUSINESS SUMMARY: AMGEN, INC. 48
TABLE 4 BUSINESS SUMMARY: NOVARTIS AG 51
TABLE 5 BUSINESS SUMMARY: ELI LILLY & COMPANY LTD. 54
TABLE 6 BUSINESS SUMMARY: PFIZER INC. 57
TABLE 7 BUSINESS SUMMARY: RADIUS HEALTH, INC. 58
TABLE 8 BUSINESS SUMMARY: TEVA PHARMACEUTICAL INDUSTRIES LTD. 61
TABLE 9 BUSINESS SUMMARY: F. HOFFMANN-LA ROCHE LTD. 63
TABLE 10 BUSINESS SUMMARY: GLAXOSMITHKLINE PLC 64
TABLE 11 BUSINESS SUMMARY: NOVO NORDISK A/S 66
TABLE 12 BUSINESS SUMMARY: MERCK & CO. 67

?
LIST OF FIGURE
Charts

CHART 1 GLOBAL PRESCRIPTION DRUG SALES, 2018-2025 ($BILLION) 9
CHART 2 GLOBAL OVER-THE-COUNTER DRUG MARKET REVENUE, 2018-2025 ($BILLION) 9
CHART 3 GLOBAL PHARMA SALES, BIOLOGICS V/S NON-BIOLOGICS (%) 10
CHART 4 GLOBAL PHARMACEUTICAL SALES BY REGION, 2018 10
CHART 5 GLOBAL PHARMACEUTICAL R&D SPENDING (2010-2017) 11
CHART 6 PHARMACEUTICAL DRUGS BY SALES, 2018 ($BILLION) 12
CHART 7 RESEARCH METHODOLOGY OF GLOBAL OSTEOPOROSIS DRUGS MARKET 15
CHART 8 GLOBAL OSTEOPOROSIS DRUGS MARKET REVENUE, 2018-2025 ($MILLION) 19
CHART 9 SEGMENTATION OF GLOBAL OSTEOPOROSIS DRUGS MARKET 24
CHART 10 PEST ANALYSIS OF GLOBAL OSTEOPOROSIS DRUGS MARKET 25
CHART 11 PORTER 5 FORCES ON GLOBAL OSTEOPOROSIS DRUGS MARKET 26
CHART 12 MARKET DYNAMICS - DRO ANALYSIS 27
CHART 13 DRO - IMPACT ANALYSIS OF GLOBAL OSTEOPOROSIS DRUGS MARKET 30
CHART 14 KEY STAKEHOLDERS 31
CHART 15 GLOBAL OSTEOPOROSIS DRUGS MARKET, BY DRUG CLASS, 2018 V/S 2025 ($MILLION) 32
CHART 16 GLOBAL BISPHOSPHONATES MARKET REVENUE, 2018-2025 ($MILLION) 33
CHART 17 GLOBAL PARATHYROID HORMONE THERAPY MARKET REVENUE, 2018-2025
($MILLION) 34
CHART 18 GLOBAL SELECTIVE ESTROGEN RECEPTOR MODULATOR MARKET REVENUE,
2018-2025 ($MILLION) 35
CHART 19 GLOBAL RANK LIGAND INHIBITORS MARKET REVENUE, 2018-2025 ($MILLION) 36
CHART 20 GLOBAL BIOSIMILARS MARKET REVENUE, 2018-2025 ($MILLION) 37
CHART 21 GLOBAL OTHERS MARKET REVENUE, 2018-2025 ($MILLION) 38
CHART 22 GLOBAL OSTEOPOROSIS DRUGS MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 V/S
2025 (%) 39
CHART 23 OSTEOPOROSIS DRUGS MARKET REVENUE IN NORTH AMERICA, 2018-2025 ($MILLION) 40
CHART 24 OSTEOPOROSIS DRUGS MARKET REVENUE IN EUROPE, 2018-2025 ($MILLION) 42
CHART 25 OSTEOPOROSIS DRUGS REVENUE IN ASIA PACIFIC, 2018-2025 ($MILLION) 43
CHART 26 OSTEOPOROSIS DRUGS MARKET REVENUE IN REST OF THE WORLD, 2018-2025 ($MILLION) 44





OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com